Clinical Trials : Lymphoma, T-Cell, Peripheral


Recruiting	: Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma : Peripheral T Cell Lymphoma : 2016-10-21 : Drug: Chidamide Chidamide is given to the patients as described, and drug concentration is measured in p
Completed	: E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma : Peripheral T-Cell Lymphoma : 2011-07-18 : Biological: denileukin diftitox (E7777) E7777 will be administered by intravenous (IV) infusion for 5 da
Active, not recruiting	: Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry : Peripheral T-cell Lymphoma : 2010-04-23
Not yet recruiting	: Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma : Peripheral T Cell Lymphoma : 2016-07-24 : Drug: Chidamide with ICE regimen Chidamide and ICE regimen, dosage described in arm description
Recruiting	: Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma : Peripheral T Cell Lymphoma : 2016-04-19 : Drug: Chidamide